| scholarly article | Q13442814 |
| P50 | author | William Reinhold | Q42631974 |
| Edward H. Oldfield | Q90685730 | ||
| P2093 | author name string | Saxena A | |
| Ali IU | |||
| Clark WC | |||
| Robertson JT | |||
| Merrill MJ | |||
| Berkman RA | |||
| Monacci WT | |||
| P2860 | cites work | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 |
| Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor | Q28567368 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
| Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation | Q33656940 | ||
| Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues | Q33713058 | ||
| Vascular structures in brain tumors | Q34045197 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance | Q34255631 | ||
| Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells | Q34306017 | ||
| Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis | Q34578752 | ||
| The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing | Q34582371 | ||
| Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels | Q36230478 | ||
| Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors | Q37370535 | ||
| Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain | Q37413174 | ||
| Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line | Q37694752 | ||
| Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. | Q40822298 | ||
| Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines | Q41642423 | ||
| Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration | Q41711674 | ||
| Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors | Q43588229 | ||
| Aortic smooth muscle cells express and secrete vascular endothelial growth factor | Q43655025 | ||
| An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. | Q44016128 | ||
| Insulin-like growth factor-I receptors in human glial tumors | Q44487001 | ||
| Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). | Q44751342 | ||
| Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. | Q45052632 | ||
| Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family | Q46135963 | ||
| Simple method for quantitation of enhanced vascular permeability. | Q46605899 | ||
| Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone | Q48173615 | ||
| Determinants for the establishment of permanent tissue culture lines from human gliomas. | Q48622697 | ||
| Localization of acidic and basic fibroblast growth factor mRNA in human brain tumors | Q48659153 | ||
| Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. | Q48739136 | ||
| Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression | Q48794685 | ||
| Expression of transforming growth factor alpha in human gliomas | Q48841362 | ||
| Immunohistochemical localization of basic fibroblast growth factor in astrocytomas | Q48859069 | ||
| Further characterization of malignant glioma-derived vascular permeability factor. | Q55486146 | ||
| Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
| Human vascular permeability factor. Isolation from U937 cells | Q69385781 | ||
| A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines | Q69614850 | ||
| Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor | Q70264729 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| endothelium | Q111140 | ||
| P304 | page(s) | 153-159 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms | |
| P478 | volume | 91 |
| Q46107099 | A mathematical model for self-limiting brain tumors |
| Q40297313 | AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma |
| Q37788585 | Aberrant signaling pathways in meningiomas |
| Q28082908 | Adaptation to antiangiogenic therapy in neurological tumors |
| Q48344191 | Added Value of Arterial Spin-Labeling MR Imaging for the Differentiation of Cerebellar Hemangioblastoma from Metastasis. |
| Q48717782 | Adenoviral modification of mouse brain derived endothelial cells, bEnd3, to induce apoptosis by vascular endothelial growth factor |
| Q55475638 | Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme: what does it tell us about the models and about glioblastoma biology and therapy? |
| Q38472948 | Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells |
| Q35215691 | Angiogenesis and vasculogenesis in pregnancy |
| Q40961541 | Angiogenesis in malignant gliomas |
| Q38034321 | Angiogenesis in neurological disorders: a review |
| Q40922411 | Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects |
| Q40400185 | Angiogenesis: models and modulators. |
| Q28577585 | Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain |
| Q35207666 | Angiogenic factors in the central nervous system |
| Q30498863 | Angiogenic growth factors in neural embryogenesis and neoplasia |
| Q34997337 | Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption |
| Q35104246 | Anti-angiogenic agents for the treatment of brain tumors |
| Q55075615 | Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. |
| Q74505899 | Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer |
| Q47965692 | Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels |
| Q90315318 | Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma |
| Q37159492 | Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer. |
| Q30278444 | Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease |
| Q26781915 | CXCR4 in breast cancer: oncogenic role and therapeutic targeting |
| Q41118765 | Cellular and molecular pathology of medulloblastoma |
| Q47577124 | Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma |
| Q33415517 | Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor |
| Q36623505 | Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers |
| Q41016238 | Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas |
| Q36987703 | Clinical neurosciences in the decade of the brain: hypotheses in neuro-oncology. VEG/PF acts upon the actin cytoskeleton and is inhibited by dexamethasone: relevance to tumor angiogenesis and vasogenic edema. |
| Q73614411 | Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL) |
| Q39036591 | Cloning and expression of the functional human anti-vascular endothelial growth factor (VEGF) using the pcDNA3.1 vector and the human chronic myelogenous leukemia cell line K562. |
| Q57181734 | Comparative Histologic and Molecular Analysis of 2 Recurrent Lesions Showing Different Magnetic Resonance Imaging Responses After Bevacizumab Treatment: Report of a Case of Anaplastic Astrocytoma |
| Q36622433 | Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas |
| Q33868792 | Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation |
| Q80425903 | Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas |
| Q38233076 | Current advances in understanding and managing secondary brain metastasis |
| Q41111895 | Cytokines in tumour growth, migration and metastasis |
| Q30597009 | Delivery of imaging agents into brain |
| Q41446853 | Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? |
| Q35770177 | Development of novel targeted therapies in the treatment of malignant glioma |
| Q28582999 | Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells |
| Q46122468 | Differential expression of VEGF ligands and receptors in prostate cancer |
| Q36293040 | Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. |
| Q48853556 | Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging |
| Q98232475 | Diffuse large B cell lymphoma of the central nervous system presenting with intratumoral hemorrhage: a case report and literature review |
| Q78704136 | Distribution of vascular endothelial growth factor (VEGF) in prostate disease |
| Q48679475 | Dogs are man's best friend: in sickness and in health |
| Q37357812 | Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells |
| Q37778052 | Drug or vaccine?: selecting the appropriate treatment for malignant glioma patients |
| Q30616602 | Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors |
| Q54975591 | Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8. |
| Q36812917 | Dural arteriovenous fistula of the sphenobasilar sinus with concomitant meningioma: case report and review of the literature |
| Q48219894 | Dynamic Contrast-Enhanced MR Perfusion of Intradural Spinal Lesions. |
| Q93195046 | Effect of bevacizumab against cystic components of brain tumors |
| Q42246512 | Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells |
| Q35786262 | Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs |
| Q35796234 | Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. |
| Q29540607 | Expression of hypoxia-inducible factor 1? in brain tumors |
| Q47992994 | Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans |
| Q40875496 | Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas |
| Q36617680 | Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers |
| Q55476076 | Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. |
| Q36431375 | Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels |
| Q78143884 | Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms |
| Q50508084 | Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice. |
| Q53425142 | Expression of vascular endothelial growth factor in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. |
| Q46293733 | Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment |
| Q47682604 | Expression of vascular endothelial growth factor in normal pituitary cells and pituitary adenomas producing adrenocorticotropic hormone |
| Q77349652 | Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma |
| Q77919675 | Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers |
| Q34431307 | Glial ontogeny and glial neoplasia: the search for closure |
| Q28075735 | Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms |
| Q48257777 | Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma |
| Q41697538 | Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review |
| Q41100541 | How tumors become angiogenic |
| Q52524665 | Human retinoblastoma: a morphological study of apoptotic, leukocytic, and vascular elements. |
| Q71740152 | Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures |
| Q40135797 | Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. |
| Q48332534 | Identification of molecular subtypes of glioblastoma by gene expression profiling |
| Q43946680 | Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases |
| Q49548083 | In Memoriam: Edward H. Oldfield, MD, 1947 to 2017. |
| Q48027890 | In vivo assessment of angioarchitecture and microcirculation in experimental liver cancer: a new model in rats |
| Q73908738 | Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma |
| Q41866566 | Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas |
| Q33655353 | Influence of host microvascular environment on tumour vascular endothelium |
| Q48293100 | Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair |
| Q48154100 | Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3. |
| Q48585558 | Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas |
| Q33832620 | Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor |
| Q29614729 | Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo |
| Q36636478 | Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 |
| Q53454220 | Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. |
| Q47682626 | Localization of vascular endothelial growth factor in nontumorous human pituitaries |
| Q30791911 | MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause |
| Q55463664 | Magnetic Resonance Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion Imaging in the Diagnosis of Posterior Fossa Hemangioblastomas and Pilocytic Astrocytomas |
| Q36336679 | Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities |
| Q24561970 | Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor |
| Q95812253 | Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas |
| Q40928364 | Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene |
| Q41106141 | Modulation of motility and proliferation of glioma cells by hepatocyte growth factor |
| Q36620062 | Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia |
| Q42803718 | Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines |
| Q55473747 | Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft. |
| Q34157370 | Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma |
| Q36694450 | Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours |
| Q36363657 | Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis |
| Q48140644 | Pathogenesis of peri-tumoral edema in intracranial meningiomas. |
| Q34722935 | Pathological significance of vascular endothelial growth factor A isoform expression in human cancer |
| Q48255033 | Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply |
| Q33627763 | Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. |
| Q33710967 | Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma |
| Q34304154 | Pituicytoma of the neurohypophysis: analysis of cell proliferation biomarkers |
| Q33727536 | Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer |
| Q37285776 | Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene |
| Q33657663 | Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody |
| Q34256198 | Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM) |
| Q36115661 | Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer |
| Q78148689 | Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells |
| Q36897801 | Progression of epididymal maldevelopment into hamartoma-like neoplasia in VHL disease. |
| Q48735587 | Prolonged activity of bevacizumab in adenocarcinoma of the lung with multiple brain metastases |
| Q73226531 | Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR |
| Q39132589 | Radiation up-regulates the expression of VEGF in a canine oral melanoma cell line |
| Q46632329 | Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema |
| Q39010683 | Reduced glioma infiltration in Src-deficient mice |
| Q40930925 | Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis |
| Q37278215 | Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain |
| Q41060744 | Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines |
| Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
| Q38754878 | Role of vincristine in the inhibition of angiogenesis in glioblastoma |
| Q35812724 | SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor |
| Q48182286 | Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability |
| Q24531302 | Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis |
| Q54480664 | Serum and tissue vascular endothelial growth factor levels in hydatidiform mole. |
| Q24306563 | Sexual differentiation |
| Q41844840 | Simulating vasogenic brain edema using chronic VEGF infusion |
| Q35782323 | Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. |
| Q39316156 | Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas. |
| Q56967585 | Synergy between tumor immunotherapy and antiangiogenic therapy |
| Q33722407 | Targeting cancer therapy |
| Q48027284 | The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein |
| Q40560859 | The application of 5-bromodeoxyuridine in the management of CNS tumors |
| Q73429369 | The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma |
| Q43592479 | The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor |
| Q35939261 | The potential role of vascular endothelial growth factor in the central nervous system |
| Q42704934 | The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells |
| Q39705581 | The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas |
| Q40930922 | The role of vascular endothelial growth factor in pathological angiogenesis |
| Q34602545 | The significance of immunohistochemistry in the diagnosis and therapy of neoplasms |
| Q34125421 | Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model |
| Q35011885 | Therapies directed at vascular endothelial growth factor |
| Q41111904 | Tumor angiogenesis: the pivotal role of vascular endothelial growth factor |
| Q88886485 | Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial |
| Q40394594 | Tumor invasion, proteolysis, and angiogenesis |
| Q38154959 | Tumor-associated edema in brain cancer patients: pathogenesis and management |
| Q55002777 | Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer. |
| Q43580641 | VEGF 165 Expressed by a Replication-Deficient Recombinant Adenovirus Vector Induces Angiogenesis In Vivo |
| Q55478726 | VEGF and bFGF mRNA are expressed in ethylnitrosourea-induced experimental rat gliomas. |
| Q34178821 | VEGF in brain tumors |
| Q46114029 | VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines |
| Q42805271 | VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways |
| Q55064617 | VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. |
| Q36677407 | VEGF/VEGFR signalling as a target for inhibiting angiogenesis |
| Q38782019 | VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans |
| Q74453859 | Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas |
| Q73129419 | Vascular endothelial growth factor |
| Q74080242 | Vascular endothelial growth factor |
| Q36843454 | Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610. |
| Q36695319 | Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value |
| Q36292182 | Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer |
| Q48843662 | Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro |
| Q73585854 | Vascular endothelial growth factor and its receptors in normal human testicular tissue |
| Q48727704 | Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. |
| Q40753743 | Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival |
| Q73576045 | Vascular endothelial growth factor expression under ischemic stress in human meningiomas |
| Q48237868 | Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors |
| Q48363690 | Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia |
| Q48465059 | Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats |
| Q45990804 | Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. |
| Q73047951 | Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? |
| Q28469224 | Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1 |
| Q40688027 | Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability |
| Q41221212 | Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas |
| Q40801255 | Vascular permeability factor (VPF, VEGF) in tumor biology |
| Q41663045 | Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis |
| Q41744340 | Vascular permeability/vascular endothelial growth factors: a potential role in the pathogenesis and treatment of vascular diseases |
| Q35104368 | Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes |
| Q41510549 | Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model |
| Q39470558 | mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells |
| Q28180159 | von Hippel-Lindau disease |
| Q38474808 | von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease |
Search more.